MSA
BLUE

Marino Stram & Associates’s bluebird bio BLUE Stock Holding History

Marino Stram & Associates’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1
Closed -$1K – 138
2019
Q1 		$1K Hold
1
– – ﹤0.01% 572
2018
Q4 		$1K Buy
+1
New +$1.53K ﹤0.01% 538

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marino Stram & Associates's BLUE Position: Q2 2019 in Review

Marino Stram & Associates sold out of bluebird bio (BLUE) in Q2 2019, closing a stake of 1 share — an estimated $1K sold.

Marino Stram & Associates first reported a position in BLUE in Q4 2018 and held it in 2 quarters. The position peaked at $1K in Q1 2019. 273 funds tracked by Wall St. Rank hold BLUE as of Q2 2019.

  • Marino Stram & Associates reported no remaining bluebird bio position as of Q2 2019 after selling out during the quarter.
  • Marino Stram & Associates sold 1 bluebird bio share in Q2 2019, an estimated $1K.
  • Marino Stram & Associates first reported a position in bluebird bio in Q4 2018 and held it in 2 quarters.
  • Marino Stram & Associates's bluebird bio position peaked at $1K in Q1 2019.
  • 273 funds tracked by Wall St. Rank held bluebird bio as of Q2 2019.

Based on Marino Stram & Associates's 13F filing for Q2 2019, filed 19 Jul 2019.